Pharmaceutical compositions comprising alkanoyl l-carnitine in combination with a statine for treating pathologies brought about by an altered lipid metabolism
CA 2295748 A1 · Owner: Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. · Inventors: Cavazza, Claudio
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The co-ordinated use of an alkanoyl L-carnitine (e.g. propionyl L-carnitine) and a statine (e.g. simvastatin) is disclosed for treating pathologies brought about by an altered lipid metabolism, wherein by co-ordinated use both the substantially contemporaneous co-administration of the two active ingredients and the administration of a combination composition comprising a mixture of the two active ingredients, is meant.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 18, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 18, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 18, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.